🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Stanford BMT & Cell Therapy is officially a 7-year Core Clinical Center! Kudos to Lori Muffly & the team for this prestigious recognition from the NIH NHLBI & National Cancer Institute. Here's to advancing groundbreaking research!

Celebrated hematologist Fred Appelbaum’s new book, Living Medicine, is part history, part biography — and a loving tribute to those who transformed a kernel of an idea into a lifesaving therapy and medical discipline: ow.ly/5rsY50SAo7i #BoneMarrowTransplant #BMT Lori Muffly

Halloween season is upon us

Shortly after a patient received CAR T-cell therapy for relapsed CNS lymphoma, an aggressive CAR+ T-cell lymphoma was diagnosed. Subsequent analysis revealed the presence of an abnormal clone in an early apheresis specimen. Read the Brief Report: nej.md/3BuToVM

Important work by the real world consortium team! Surbhi Sidana, MD

Interested in a BMT-Cell Therapy Fellowship? Come join our awesome team at Stanford. If interested, please send cover letter, CV & 3 references (inc. director of current fellowship program) to [email protected].

Our consensus recommendations for infection prevention and management for CAR-T therapy

1/ 🚨 Now in Blood Cancer Journal - our multicenter description of IEC-associated enterocolitis as a novel toxicity of CAR-T in myeloma #MMsm. Typically non-bloody Gr3+ diarrhea starting ~3 mo after ide-cel or cilta-cel: 36% cases fatal in our series (n=14). nature.com/articles/s4140…

Congratulations Dr. Bharadwaj and grateful to Dr. Weng for leading this fellowship. One of the best experiences I’ve had in my career :)

Learn more about Urvi Shah's new study that reveals a #fiber diet may delay #multiplemyeloma. #ASH24 ASH #bloodcancers

CONGRESS | #ASH24 | Rahul Banerjee, MD, FACP UW Medicine Fred Hutch Cancer Center discusses the rationale for moving toward urine-free response criteria in #MultipleMyeloma, showing little discordance between urine and urine-free response data, with a higher number of patients being evaluable for

Excited by cell-therapy innovations at ASH? Join the Stanford team as a transplant/cell-therapy fellow to get in on the fun. Send cover letter, CV & 3 references (inc. director of current fellowship program) to [email protected].

#ASH24 #bmtsm Dr Melody Smith presented Stanford trial combining academic allogeneic transplant and donor CAR-T in ALL. Congrats Melody, ⁦⁦Lori Muffly⁩ and colleagues on this terrific team effort with academic CAR manufacturing from donors! ⁦Stanford BMT & Cell Therapy⁩

Our study on dietary risk factors for MGUS made the list of the 2024 Blood Advances most read articles Janine M. Joseph ashpublications.org/bloodadvances/…

Valuable perspective on the regulatory structures necessary to make automated prescribing safe -- but perhaps more important for getting an evil robot infographic in Nature!

On being a good doctor Part II (after being on the other side as a patient advocate) - Understand the patient and the clinical problem they face. It is more than just analyzing lab results and scans. 90% of diagnosis is history. - History taking/acquisition is a skill.

Dr Kaur - wonderful job presenting 117 RRMM pats treated with Anito-cel => ORR 97%, no late neurotoxicity to date - interesting for sure

⁦Gurbakhash Kaur⁩ is an absolute superstar ! #mmsm ⁦The Tisch Cancer Institute⁩ ⁦Mount Sinai Health System⁩